Chibaudel, B.; Carola, E.; Mekranter, H.; Goyer, P.; Saget, A.; Oberlin, O.; Marijon, H.; Richa, H.; Iurisci, I.; Gervais, H.;
et al. Quantitative ctDNA Profiling of RAS Mutations as a Prognostic Biomarker in Metastatic Colorectal Cancer. Int. J. Mol. Sci. 2026, 27, 8.
https://doi.org/10.3390/ijms27010008
AMA Style
Chibaudel B, Carola E, Mekranter H, Goyer P, Saget A, Oberlin O, Marijon H, Richa H, Iurisci I, Gervais H,
et al. Quantitative ctDNA Profiling of RAS Mutations as a Prognostic Biomarker in Metastatic Colorectal Cancer. International Journal of Molecular Sciences. 2026; 27(1):8.
https://doi.org/10.3390/ijms27010008
Chicago/Turabian Style
Chibaudel, Benoist, Elisabeth Carola, Hamid Mekranter, Perrine Goyer, Arnaud Saget, Olivier Oberlin, Hélène Marijon, Hubert Richa, Ida Iurisci, Honorine Gervais,
and et al. 2026. "Quantitative ctDNA Profiling of RAS Mutations as a Prognostic Biomarker in Metastatic Colorectal Cancer" International Journal of Molecular Sciences 27, no. 1: 8.
https://doi.org/10.3390/ijms27010008
APA Style
Chibaudel, B., Carola, E., Mekranter, H., Goyer, P., Saget, A., Oberlin, O., Marijon, H., Richa, H., Iurisci, I., Gervais, H., Perez-Staub, N., Dainese, L., Pujol, P., Toledano, A., Bachet, J.-B., & de Gramont, A.
(2026). Quantitative ctDNA Profiling of RAS Mutations as a Prognostic Biomarker in Metastatic Colorectal Cancer. International Journal of Molecular Sciences, 27(1), 8.
https://doi.org/10.3390/ijms27010008
